SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Saracen who wrote (852)6/3/1998 1:01:00 AM
From: Wisee   of 1185
 
Saracen,

Let's say after the financing Nortran has 40 million shares outstanding, then it's price should be around $3.15 if we are comparing it to Forbes Medi-Tech (present market cap is $126 million). But remember, Nortran will have approx. $18 million in cash, while Forbes Medi-Tech presently has $9 million.

In regards to the financing, I think it will done between $1.80 - $2.00.
It will be interesting to see who takes a position in this financing.

Wisee
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News